Kevin Caliendo
Stock Analyst at UBS
(3.78)
# 1,985
Out of 5,022 analysts
404
Total ratings
53.3%
Success rate
4.4%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CERT Certara | Downgraded: Hold | $10 | $9.36 | +6.84% | 1 | Sep 30, 2026 | |
| CRL Charles River Laboratories International | Initiated Coverage: Buy | $357 | $290.19 | +23.02% | 1 | Sep 30, 2026 | |
| FTRE Fortrea Holdings | Initiated Coverage: Hold | $22 | $20.00 | +10.00% | 1 | Sep 30, 2026 | |
| ICLR ICON Public Limited Company | Downgraded: Hold | $195 | $162.02 | +20.36% | 1 | Sep 30, 2026 | |
| IQV IQVIA Holdings | Initiated Coverage: Buy | $345 | $258.21 | +33.61% | 1 | Sep 30, 2026 | |
| MEDP Medpace Holdings | Initiated Coverage: Hold | $673 | $599.47 | +12.27% | 1 | Sep 30, 2026 | |
| MDLN Medline | Rated: Buy | $50 → $43 | $35.61 | +20.75% | 4 | Sep 25, 2026 | |
| NVST Envista Holdings | Reiterated: Hold | $25 → $27 | $23.46 | +15.09% | 6 | Sep 18, 2026 | |
| LH Labcorp Holdings | Reiterated: Buy | $361 → $380 | $308.49 | +23.18% | 22 | Sep 11, 2026 | |
| DGX Quest Diagnostics | Reiterated: Hold | $232 → $245 | $233.33 | +5.00% | 20 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $126 → $118 | $86.46 | +36.48% | 36 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $5.60 | +78.57% | 19 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $19 | $30.31 | -37.31% | 1 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $1.5 | $0.5052 | +196.91% | 20 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 → $3.75 | $3.28 | +14.33% | 9 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $412 → $430 | $309.05 | +39.14% | 27 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,050 → $1,080 | $902.28 | +19.70% | 33 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $89 → $94 | $84.88 | +10.74% | 11 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $33 | $24.81 | +33.01% | 3 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $186 → $189 | $143.74 | +31.49% | 26 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $260 → $274 | $228.30 | +20.02% | 23 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $5.52 | +8.70% | 16 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $3.46 | +44.51% | 8 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $13 | $11.83 | +9.89% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $17 | $8.67 | +96.08% | 20 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $82 → $78 | $87.85 | -11.21% | 4 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $390 → $375 | $270.53 | +38.62% | 11 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $18 | $7.94 | +126.70% | 13 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $374 → $180 | $189.54 | n/a | 7 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 → $9 | $12.39 | n/a | 9 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $250 → $285 | $388.36 | n/a | 12 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $72 → $79 | $62.99 | n/a | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $520 → $640 | $371.90 | n/a | 10 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $595 → $610 | $386.43 | n/a | 3 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $180 → $175 | $256.03 | n/a | 4 | Oct 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $15.67 | n/a | 1 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 → $8 | $5.00 | n/a | 2 | Mar 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $112.51 | n/a | 1 | Jan 30, 2018 |
Certara
Sep 30, 2026
Downgraded: Hold
Price Target: $10
Current: $9.36
Upside: +6.84%
Charles River Laboratories International
Sep 30, 2026
Initiated Coverage: Buy
Price Target: $357
Current: $290.19
Upside: +23.02%
Fortrea Holdings
Sep 30, 2026
Initiated Coverage: Hold
Price Target: $22
Current: $20.00
Upside: +10.00%
ICON Public Limited Company
Sep 30, 2026
Downgraded: Hold
Price Target: $195
Current: $162.02
Upside: +20.36%
IQVIA Holdings
Sep 30, 2026
Initiated Coverage: Buy
Price Target: $345
Current: $258.21
Upside: +33.61%
Medpace Holdings
Sep 30, 2026
Initiated Coverage: Hold
Price Target: $673
Current: $599.47
Upside: +12.27%
Medline
Sep 25, 2026
Rated: Buy
Price Target: $50 → $43
Current: $35.61
Upside: +20.75%
Envista Holdings
Sep 18, 2026
Reiterated: Hold
Price Target: $25 → $27
Current: $23.46
Upside: +15.09%
Labcorp Holdings
Sep 11, 2026
Reiterated: Buy
Price Target: $361 → $380
Current: $308.49
Upside: +23.18%
Quest Diagnostics
Sep 8, 2026
Reiterated: Hold
Price Target: $232 → $245
Current: $233.33
Upside: +5.00%
Sep 3, 2026
Rated: Buy
Price Target: $126 → $118
Current: $86.46
Upside: +36.48%
Aug 24, 2026
Rated: Buy
Price Target: $10
Current: $5.60
Upside: +78.57%
Aug 14, 2026
Initiated Coverage: Hold
Price Target: $19
Current: $30.31
Upside: -37.31%
Aug 13, 2026
Reiterated: Hold
Price Target: $4.5 → $1.5
Current: $0.5052
Upside: +196.91%
Aug 13, 2026
Reiterated: Hold
Price Target: $2 → $3.75
Current: $3.28
Upside: +14.33%
Aug 6, 2026
Reiterated: Buy
Price Target: $412 → $430
Current: $309.05
Upside: +39.14%
Aug 6, 2026
Reiterated: Buy
Price Target: $1,050 → $1,080
Current: $902.28
Upside: +19.70%
Aug 5, 2026
Reiterated: Hold
Price Target: $89 → $94
Current: $84.88
Upside: +10.74%
Jul 30, 2026
Reiterated: Buy
Price Target: $37 → $33
Current: $24.81
Upside: +33.01%
Jul 23, 2026
Reiterated: Hold
Price Target: $186 → $189
Current: $143.74
Upside: +31.49%
Jul 20, 2026
Rated: Buy
Price Target: $260 → $274
Current: $228.30
Upside: +20.02%
May 15, 2026
Reiterated: Hold
Price Target: $6
Current: $5.52
Upside: +8.70%
May 8, 2026
Reiterated: Buy
Price Target: $5
Current: $3.46
Upside: +44.51%
May 8, 2026
Reiterated: Buy
Price Target: $12 → $13
Current: $11.83
Upside: +9.89%
May 7, 2026
Reiterated: Buy
Price Target: $18 → $17
Current: $8.67
Upside: +96.08%
May 6, 2026
Reiterated: Hold
Price Target: $82 → $78
Current: $87.85
Upside: -11.21%
Feb 9, 2026
Reiterated: Buy
Price Target: $390 → $375
Current: $270.53
Upside: +38.62%
Oct 31, 2025
Reiterated: Hold
Price Target: $17 → $18
Current: $7.94
Upside: +126.70%
Jul 25, 2025
Reiterated: Hold
Price Target: $374 → $180
Current: $189.54
Upside: n/a
May 8, 2025
Reiterated: Hold
Price Target: $12 → $9
Current: $12.39
Upside: n/a
Feb 24, 2025
Reiterated: Hold
Price Target: $250 → $285
Current: $388.36
Upside: n/a
Dec 21, 2023
Reiterated: Hold
Price Target: $72 → $79
Current: $62.99
Upside: n/a
Oct 16, 2023
Upgraded: Buy
Price Target: $520 → $640
Current: $371.90
Upside: n/a
Oct 24, 2022
Reiterated: Buy
Price Target: $595 → $610
Current: $386.43
Upside: n/a
Oct 3, 2022
Reiterated: Hold
Price Target: $180 → $175
Current: $256.03
Upside: n/a
Mar 9, 2022
Upgraded: Buy
Price Target: n/a
Current: $15.67
Upside: n/a
Mar 3, 2020
Reiterated: Hold
Price Target: $12 → $8
Current: $5.00
Upside: n/a
Jan 30, 2018
Upgraded: Buy
Price Target: n/a
Current: $112.51
Upside: n/a